Genic Balance Sheet Health
Financial Health criteria checks 4/6
Genic has a total shareholder equity of ₩11.5B and total debt of ₩7.0B, which brings its debt-to-equity ratio to 60.7%. Its total assets and total liabilities are ₩23.4B and ₩11.9B respectively.
Key information
60.7%
Debt to equity ratio
₩7.00b
Debt
Interest coverage ratio | n/a |
Cash | ₩1.84b |
Equity | ₩11.53b |
Total liabilities | ₩11.87b |
Total assets | ₩23.40b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A123330's short term assets (₩9.4B) do not cover its short term liabilities (₩11.7B).
Long Term Liabilities: A123330's short term assets (₩9.4B) exceed its long term liabilities (₩171.5M).
Debt to Equity History and Analysis
Debt Level: A123330's net debt to equity ratio (44.7%) is considered high.
Reducing Debt: A123330's debt to equity ratio has reduced from 66.7% to 60.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A123330 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A123330 has sufficient cash runway for 1.3 years if free cash flow continues to grow at historical rates of 51% each year.